Kiran Reddy

Private Equity Analyst at BLACKSTONE INC.

48 year

Finance

Health Technology

Commercial Services

Profile

Kiran Reddy is the founder of Praxis Precision Medicines, Inc. (founded in 2015) where he held the title of Director from 2020 to 2021.
He is currently working as a Managing Director & Venture partner at Blackstone, Inc. and as a Senior Managing Director at Blackstone Life Sciences Advisors LLC (since 2018 and 2022 respectively).
Previously, he worked as a Senior Director at Biogen, Inc. from 2014 to 2016, as a Consultant at The Lewin Group, Inc., as a Venture Partner at Clarus Ventures LLC from 2015 to 2018, as a Senior Associate at Third Rock Ventures LLC from 2008 to 2010, and as the Head of Business Development & Operations at SAGE Therapeutics, Inc. from 2012 to 2013.
Dr. Reddy completed his undergraduate degree at Georgetown University in 1999 and obtained an MBA in 2004.
He also holds a doctorate degree, which was conferred in 2003.

Latest news about Kiran Reddy

05-27	Blackstone : GRIN Therapeutics and Angelini Pharma Enter into Exclusive Collaboration to Develop and Commercialize Radiprodil Outside North America	PU
16/05/24	Blackstone Life Sciences Launches Uniquity Bio to Develop Novel Medicines in Immunology and Inflammation	AQ
15/05/24	Blackstone Life Sciences Launches Uniquity Bio to Develop Novel Medicines in Immunology & Inflammation	BU
27/10/22	PTC Therapeutics Announces Strategic Financing Collaboration with Blackstone with up to $1 Billion in Funding	PR
15/04/21	PRAXIS PRECISION MEDICINES, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ

Kiran Reddy active positions

Companies	Position	Start
BLACKSTONE INC.	Private Equity Analyst	04/01/2020
Blackstone Life Sciences Advisors LLC Blackstone Life Sciences Advisors LLC Blackstone Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields on pharmaceutical, biotechnology and medical technology sectors. It provides financing for growth stage transactions.	Private Equity Investor	30/11/2018

All active positions of Kiran Reddy

Former positions of Kiran Reddy

Companies	Position	End
PRAXIS PRECISION MEDICINES, INC.	Chief Executive Officer	31/03/2020
Clarus Ventures LLC Clarus Ventures LLC Investment ManagersFinance Clarus Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of biopharmaceutical and medical technology. It participates in early stage capital transactions. Clarus Ventures acquired by Blackstone Inc on November 30, 2018. Clarus ventures will become Blackstone Life Sciences.	Private Equity Investor	10/01/2018
BIOGEN INC.	Corporate Officer/Principal	05/01/2016
The Lewin Group, Inc. The Lewin Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides healthcare consulting services	Corporate Officer/Principal	-
SAGE THERAPEUTICS, INC.	Chief Operating Officer	13/03/2013

See the detail of Kiran Reddy's experience

Training of Kiran Reddy

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kiran Reddy's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Biogen, Inc. Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases	Health Technology
The Lewin Group, Inc. The Lewin Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides healthcare consulting services	Commercial Services
Georgetown University Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Clarus Ventures LLC Clarus Ventures LLC Investment ManagersFinance Clarus Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of biopharmaceutical and medical technology. It participates in early stage capital transactions. Clarus Ventures acquired by Blackstone Inc on November 30, 2018. Clarus ventures will become Blackstone Life Sciences.	Finance
Blackstone, Inc. Blackstone, Inc. Investment ManagersFinance Provides investment and fund management services	Finance
Third Rock Ventures LLC Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector. It provides financing for early stage capital requirements. The firm also acts as a lead investor.	Finance
SAGE Therapeutics, Inc. SAGE Therapeutics, Inc. Develops and commercializes novel medicines for central nervous system disorders
Praxis Precision Medicines, Inc. Praxis Precision Medicines, Inc. Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders
Blackstone Life Sciences Advisors LLC Blackstone Life Sciences Advisors LLC Blackstone Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields on pharmaceutical, biotechnology and medical technology sectors. It provides financing for growth stage transactions.